GENI vs RSI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

GENI

59.9
AI Score
VS
GENI Wins

RSI

55.2
AI Score

Investment Advisor Scores

GENI

60score
Recommendation
HOLD

RSI

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GENI RSI Winner
Revenue 669.49M 1.13B RSI
Net Income -111.58M 33.31M RSI
Net Margin -16.7% 2.9% RSI
Operating Income -151.33M 87.42M RSI
ROE -15.4% 22.6% RSI
ROA -9.9% 5.1% RSI
Total Assets 1.13B 658.51M GENI
Cash 280.56M 336.26M RSI
Current Ratio 1.56 1.93 RSI
Free Cash Flow 64.54M 164.24M RSI

Relative Price Performance (Last 90 Days)

GENI 1M: +9.0% · 3M: +58.9% RSI 1M: -13.9% · 3M: -4.2%

Current Technical Phase

GENI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.9% over 20 days), RSI 57

RSI (14): 57.4 · Price: $6.93

RSI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.9 · Price: $26.91

Fundamentals Snapshot

Metric GENI RSI
Market Cap
Forward P/E 7.1 32.0
Trailing P/E 92.3
Revenue (TTM)
Revenue Growth 0.3% 0.4%
Gross Margin 0.2% 0.3%
Operating Margin -0.2% 0.1%
EPS -0.59 0.29
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.